Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

摘要

The present invention relates to the CGRP antagonists of general formula wherein A, X, D, E, G, M, Q and R¹ to R³ are defined as in claim 1, the tautomers, the isomers, the diastereomers, the enantiomers, the hydrates thereof, the mixtures thereof and the salts thereof and the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids, pharmaceutical compositions containing these compounds, the use thereof and processes for the preparation thereof.